Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics

DSpace/Manakin Repository

Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics

Citable link to this page


Title: Identification of β-Secretase (BACE1) Substrates Using Quantitative Proteomics
Author: Elias, Joshua E.; Maas, Stefan; Gygi, Steven P.; Selkoe, Dennis J.; Hemming, Matthew Louis

Note: Order does not necessarily reflect citation order of authors.

Citation: Hemming, Matthew L., Joshua E. Elias, Steven P. Gygi, and Dennis J. Selkoe. 2009. Identification of β-Secretase (BACE1) substrates using quantitative proteomics. PLoS ONE 4(12): e8477.
Full Text & Related Files:
Abstract: β-site APP cleaving enzyme 1 (BACE1) is a transmembrane aspartyl protease with a lumenal active site that sheds the ectodomains of membrane proteins through juxtamembrane proteolysis. BACE1 has been studied principally for its role in Alzheimer's disease as the β-secretase responsible for generating the amyloid-β protein. Emerging evidence from mouse models has identified the importance of BACE1 in myelination and cognitive performance. However, the substrates that BACE1 processes to regulate these functions are unknown, and to date only a few β-secretase substrates have been identified through candidate-based studies. Using an unbiased approach to substrate identification, we performed quantitative proteomic analysis of two human epithelial cell lines stably expressing BACE1 and identified 68 putative β-secretase substrates, a number of which we validated in a cell culture system. The vast majority were of type I transmembrane topology, although one was type II and three were GPI-linked proteins. Intriguingly, a preponderance of these proteins are involved in contact-dependent intercellular communication or serve as receptors and have recognized roles in the nervous system and other organs. No consistent sequence motif predicting BACE1 cleavage was identified in substrates versus non-substrates. These findings expand our understanding of the proteins and cellular processes that BACE1 may regulate, and suggest possible mechanisms of toxicity arising from chronic BACE1 inhibition.
Published Version: doi: 10.1371/journal.pone.0008477
Other Sources:
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at
Citable link to this page:
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)


Search DASH

Advanced Search